Modulating satiety perception through non-invasive biomechanical innovation
A CE-marked medical device designed to support appetite regulation by targeting the mechanical component of satiety through controlled extra-parietal compression to the epigastric region.
A mechanical approach to appetite regulation
GASTER control® applies controlled extra-parietal compression to the epigastric region, targeting the mechanical component of satiety. No pharmacological action, no internal device, no surgery — a purely external, adjustable, and reversible approach designed for daily use.
To understand this mechanism, it is essential to consider satiety within the broader context of appetite regulation. Understanding the role of satiety
The Extra-Parietal Balloon (BEP™)
An inflatable biomechanical structure designed for controlled application to the epigastric region, engineered for comfort, reproducibility, and daily wearability.
A complementary tool within structured care pathways
GASTER control® is designed for integration alongside nutritional guidance, behavioral support, and pharmacological or surgical strategies — not as a standalone treatment.
Pre-operative support and post-operative management of weight regain within surgical care trajectories.
Support during dose reduction, treatment discontinuation, or as a non-pharmacological relay.
Selected patients (BMI 27–30) not eligible for GLP-1 therapies, or seeking a non-invasive approach.
This approach can notably support transitions related to GLP-1 therapies.
Explore the role of GLP-1 therapies in appetite regulationFull clinical information for prescribers
Early behavioral observations
A structured clinical pathway
GASTER control® is currently undergoing multicentric observational evaluation (GC-REG-01) to document usage, tolerance, and behavioral outcomes in routine clinical practice.
~50 participants, BMI 25–40, 8-week follow-up with structured dietitian support. Data centralized on an HDS-certified platform (Obeli), with full GDPR compliance.
About GASTER Technology
GASTER Technology Limited is a Malta-based European medical device company. We develop GASTER control® as a complement to existing therapies — GLP-1 receptor agonists, bariatric surgery, dietary and behavioral support — within structured care pathways across Europe.
How can we work together?
GASTER control® is open to collaboration across clinical, commercial, and industrial environments.
Clinical documentation, prescribing information, patient selection guidance, and training materials.
Access clinical resourcesExclusive distribution, licensing agreements, and market-specific regulatory adaptation.
Explore partnership modelsIntegrate the BEP™ technology into your own wearable devices, medical textiles, or health platforms.
Discuss integrationA non-invasive biomechanical approach supporting the perception of satiety signals. Grounded in physiology, designed for clinical integration, and under continuous scientific evaluation.